会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Device and method for treatment of surface infections with nitric oxide
    • 用一氧化氮治疗表面感染的装置和方法
    • US08795222B2
    • 2014-08-05
    • US13006218
    • 2011-01-13
    • Alex StenzlerChristopher C. Miller
    • Alex StenzlerChristopher C. Miller
    • A61M37/00A61M1/00A01N59/02
    • A61M35/00A61B90/40A61H33/14A61K33/00A61L2/0094A61L15/18A61L15/44A61L2300/114A61L2300/602A61M1/0031A61M1/0088A61M13/003A61M13/006A61M2202/0275A61M2205/3334A61K2300/00
    • Topical exposure of nitric oxide gas to wounds such as chronic non-healing wounds may be beneficial in promoting healing of the wound and in preparing the wound bed for further treatment and recovery. Nitric oxide gas may be used, for example, to reduce the microbial infection and burden on these wounds, manage exudate secretion by reducing inflammation, upregulate expression of endogenous collagenase to locally debride the wound, and regulate the formation of collagen. High concentration of nitric oxide ranging from about 160 to 400 ppm may be used without inducing toxicity in the healthy cells around a wound site. Additionally, exposure to the high concentration for a first treatment period reduces the microbial burden and inflammation at the wound site and increase collagenase expression to debride necrotic tissue at the wound site. After a first treatment period with high concentration of nitric oxide, a second treatment period at a lower concentration of nitric oxide preferably ranging from about 5-20 ppm may to provided to restore the balance of nitric oxide and induce collagen expression to aid in the closure of the wound.
    • 一氧化氮气体局部暴露于伤口如慢性非愈合伤口可能有益于促进伤口愈合和制备伤口床进一步治疗和恢复。 例如,可以使用一氧化氮气体来减少这些伤口的微生物感染和负担,通过减少炎症,上调内源性胶原酶的表达来局部清创伤口并调节胶原的形成来控制渗出物分泌。 可以使用约160至400ppm范围内的高浓度一氧化氮,而不会在伤口部位周围的健康细胞中引起毒性。 此外,在第一次治疗期间暴露于高浓度可减少伤口部位的微生物负担和炎症,并增加胶原酶表达以清除伤口部位的坏死组织。 在具有高浓度一氧化氮的第一次治疗期后,可提供较低浓度的一氧化氮优选约5-20ppm的第二治疗期以恢复一氧化氮的平衡并诱导胶原表达以帮助闭合 的伤口。
    • 2. 发明授权
    • Metered dose inhaler spacer
    • 计量剂量吸入器垫片
    • US08770188B2
    • 2014-07-08
    • US13077849
    • 2011-03-31
    • Alex StenzlerSteve Han
    • Alex StenzlerSteve Han
    • A61M15/00
    • A61M15/0086A61M15/0015A61M15/0018A61M15/002A61M15/009A61M2205/3334
    • A metered dose inhaler (MDI) spacer has a body that defines a dose receiving chamber. A proximal end portion coupled between the body and a mouth port through which a metered dose may be inhaled by a user of the MDI spacer. A distal end portion is coupled with the body. A combined one-way and flow rate control valve coupled with the distal end portion is configured for permitting external airflow into and prohibiting internal airflow out of the dose receiving chamber. A collar coupled with the distal end portion is configured for receiving an actuator shaft of a metered dose inhaler and for forming a seal about an aerosol nozzle of the metered dose inhaler such that a metered dose of medication is admissible into the dose receiving chamber via the collar while airflow into and out of the dose receiving chamber via the collar is prohibited.
    • 定量吸入器(MDI)间隔物具有限定剂量接收室的主体。 连接在主体和口端口之间的近端部分,计量剂量可由MDI间隔物的使用者吸入。 远端部分与身体联接。 与远端部分结合的组合的单向和流量控制阀构造成允许外部气流进入并阻止内部空气流出剂量接收室。 与远端部分联接的套环被构造成用于接收计量剂量吸入器的致动器轴并且用于围绕计量剂量吸入器的气溶胶喷嘴形成密封,使得计量剂量的药物可以经由 在通过衣领进入和离开剂量接收室的气流被禁止的情况下。
    • 4. 发明授权
    • Venturi geometry design for flow-generator patient circuit
    • 文丘里几何设计用于流量发生器患者回路
    • US08100125B2
    • 2012-01-24
    • US11241303
    • 2005-09-30
    • Steven DuquetteAlex StenzlerSteve Han
    • Steven DuquetteAlex StenzlerSteve Han
    • A61M11/00
    • A61M16/0666A61M16/0012A61M16/0858
    • Provided is a universal interface adapted for providing continuous positive airway pressure to a patient when the interface is used with a standard ventilator. The interface is configured to operate at a supply pressure no greater than about 120 centimeters of H2O in order to deliver pressure to the patient of up to about 15 cm of H2O at a flow rate of up to about 12 liters/minute. The universal interface may comprise an interface body having a space pair of breathing passageways intersecting a corresponding of supply passageways. Each one of the breathing passageways is comprised of a patient passageway and an exhalation passageway. Each one of the supply passageways includes a jet venturi having a taper portion. Each one of the exhalation passageways includes a taper portion which tapers outwardly along a direction from the patient passageway toward the exhalation passageway.
    • 提供了一种通用接口,其适于在接口与标准通气机一起使用时向患者提供持续的正气道压力。 该界面构造成在不超过约120厘米H 2 O的供应压力下操作,以便以高达约12升/分钟的流速向患者输送高达约15cm H 2 O的压力。 通用接口可以包括具有与供应通道相对应的空间对的呼吸通道的接口体。 每个呼吸通道由患者通道和呼气通道组成。 每个供应通道包括具有锥形部分的喷射文丘里管。 每个呼气通道包括锥形部分,其沿着从患者通道朝向呼气通道的方向向外变细。
    • 6. 发明申请
    • DEVICE AND METHOD FOR TREATMENT OF SURFACE INFECTIONS WITH NITRIC OXIDE
    • 用氮氧化物处理表面感染的装置和方法
    • US20110112468A1
    • 2011-05-12
    • US13006218
    • 2011-01-13
    • Alex STENZLERChristopher C. MILLER
    • Alex STENZLERChristopher C. MILLER
    • A61M37/00
    • A61M35/00A61B90/40A61H33/14A61K33/00A61L2/0094A61L15/18A61L15/44A61L2300/114A61L2300/602A61M1/0031A61M1/0088A61M13/003A61M13/006A61M2202/0275A61M2205/3334A61K2300/00
    • Topical exposure of nitric oxide gas to wounds such as chronic non-healing wounds may be beneficial in promoting healing of the wound and in preparing the wound bed for further treatment and recovery. Nitric oxide gas may be used, for example, to reduce the microbial infection and burden on these wounds, manage exudate secretion by reducing inflammation, upregulate expression of endogenous collagenase to locally debride the wound, and regulate the formation of collagen. High concentration of nitric oxide ranging from about 160 to 400 ppm may be used without inducing toxicity in the healthy cells around a wound site. Additionally, exposure to the high concentration for a first treatment period reduces the microbial burden and inflammation at the wound site and increase collagenase expression to debride necrotic tissue at the wound site. After a first treatment period with high concentration of nitric oxide, a second treatment period at a lower concentration of nitric oxide preferably ranging from about 5-20 ppm may to provided to restore the balance of nitric oxide and induce collagen expression to aid in the closure of the wound.
    • 一氧化氮气体局部暴露于伤口如慢性非愈合伤口可能有益于促进伤口愈合和制备伤口床进一步治疗和恢复。 例如,可以使用一氧化氮气体来减少这些伤口的微生物感染和负担,通过减少炎症,上调内源性胶原酶的表达来局部清创伤口并调节胶原的形成来控制渗出物分泌。 可以使用约160至400ppm范围内的高浓度一氧化氮,而不会在伤口部位周围的健康细胞中引起毒性。 此外,在第一次治疗期间暴露于高浓度可减少伤口部位的微生物负担和炎症,并增加胶原酶表达以清除伤口部位的坏死组织。 在具有高浓度一氧化氮的第一次治疗期后,可提供较低浓度的一氧化氮优选约5-20ppm的第二治疗期以恢复一氧化氮的平衡并诱导胶原表达以帮助闭合 的伤口。